CN113968882A - Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof - Google Patents

Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof Download PDF

Info

Publication number
CN113968882A
CN113968882A CN202010718634.6A CN202010718634A CN113968882A CN 113968882 A CN113968882 A CN 113968882A CN 202010718634 A CN202010718634 A CN 202010718634A CN 113968882 A CN113968882 A CN 113968882A
Authority
CN
China
Prior art keywords
chromium
optically pure
diphenylphosphinoyl
solvent
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN202010718634.6A
Other languages
Chinese (zh)
Inventor
陆海华
王亚辉
刘娟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nanjing Tech University
Original Assignee
Nanjing Tech University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nanjing Tech University filed Critical Nanjing Tech University
Priority to CN202010718634.6A priority Critical patent/CN113968882A/en
Publication of CN113968882A publication Critical patent/CN113968882A/en
Pending legal-status Critical Current

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/655Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms
    • C07F9/6552Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring
    • C07F9/65522Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having oxygen atoms, with or without sulfur, selenium, or tellurium atoms, as the only ring hetero atoms the oxygen atom being part of a six-membered ring condensed with carbocyclic rings or carbocyclic ring systems
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J31/00Catalysts comprising hydrides, coordination complexes or organic compounds
    • B01J31/16Catalysts comprising hydrides, coordination complexes or organic compounds containing coordination complexes
    • B01J31/22Organic complexes
    • B01J31/2204Organic complexes the ligands containing oxygen or sulfur as complexing atoms
    • B01J31/2208Oxygen, e.g. acetylacetonates
    • B01J31/2226Anionic ligands, i.e. the overall ligand carries at least one formal negative charge
    • B01J31/2252Sulfonate ligands
    • B01J31/2256Sulfonate ligands being perfluorinated, i.e. comprising at least one perfluorinated moiety as substructure in case of polyfunctional ligands
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B53/00Asymmetric syntheses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01JCHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2231/00Catalytic reactions performed with catalysts classified in B01J31/00
    • B01J2231/30Addition reactions at carbon centres, i.e. to either C-C or C-X multiple bonds
    • B01J2231/32Addition reactions to C=C or C-C triple bonds
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07Optical isomers

Abstract

The invention discloses an optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone and a preparation method thereof, wherein 1-benzopyran-4-ketone and diphenylphosphine oxide are subjected to Michael addition reaction under the catalytic action of a composite catalyst to obtain the optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone. The invention creatively researches the preparation method of optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone, fills the vacancy of synthesizing the organic aryl phosphine compound in the Michael addition reaction in the metal catalysis asymmetry, effectively expands the synthesis method of the organic phosphine compound and improves the catalytic efficiency in the metal catalysis asymmetry; through the research on the conditions of raw material characteristics, ligand structures, catalytic effects and the like, the inventors select an addition catalyst and a metal to match with a corresponding solvent in a targeted manner, so that the smooth proceeding of the reaction process is ensured, and the yield, the purity and the enantioselectivity of the product are improved.

Description

Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof
Technical Field
The invention belongs to the technical field of chemical preparation, and particularly relates to optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and a preparation method thereof.
Background
Organic phosphine compounds having high optical activity are very important in synthetic chemistry. Chiral phosphonates, for example, are precursors to a number of molecules of biological and pharmaceutical interest. However, the chiral organic phosphine compound is difficult to obtain directly from nature, and often needs chemical synthesis, and the main methods are as follows: racemate resolution, synthesis using stoichiometric chiral auxiliaries and catalytic asymmetric synthesis. The racemate resolution mainly adopts chromatographic separation, so the operation is inconvenient and the racemate resolution has limitation; the chiral auxiliary is large in synthetic dosage, so that waste is caused; however, many known methods for catalyzing asymmetric synthesis of chiral phosphine still have the defects of poor substrate applicability, long reaction time and the like. Therefore, there is a need to develop more efficient metal-catalyzed asymmetric processes for synthesizing chiral phosphine compounds.
Of the many metal-catalyzed asymmetric processes, the phosphine Michael addition reaction of α, β -unsaturated ketones has received much attention and research from various scientists. Meanwhile, through research and research, the chiral double nitrogen-oxygen ligand is not reported in the phosphine Michael addition reaction; meanwhile, exocyclic α, β -unsaturated benzocycloketones are more valuable as electrophiles than the widely studied asymmetric addition of nitroolefins, α, β -unsaturated aldehydes, α, β -unsaturated esters, ketones or cyclic α, β -unsaturated enols, and we attempted to synthesize optically pure (S) -2- (diphenylphosphino) chromium-4-ones by catalyzing the addition reaction of exocyclic α, β -unsaturated benzocycloketones with diarylphosphines using metallic scandium.
Disclosure of Invention
The purpose of the invention is as follows: the invention aims to provide optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone with high yield and high product purity and a preparation method thereof aiming at the defects of the prior art.
The technical scheme is as follows: the invention relates to an optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone, which is shown as a formula (I):
Figure BDA0002599141990000021
wherein: r is 6-F, 6-Cl, 6-Br, 6-OMe, 6-CO2Me、6-NO25-Me, 6-Me, 7-Me or 8-Me;
ar is C6H5-、2-Me-C6H4-、3-Me-C6H4-、4-Me-C6H4-、4-F-C6H4-or 2-naphthyl-.
The invention also provides a preparation method of the optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone, which comprises the step of carrying out Michael addition reaction on 1-benzopyran-4-ketone and diphenylphosphine oxide under the catalytic action of a composite catalyst to obtain the optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone; the composite catalyst is a mixture of a chiral dinitrogen ligand and scandium trifluoromethanesulfonate, wherein the structural formula of the chiral dinitrogen ligand is shown as the formula (II):
Figure BDA0002599141990000022
further, as a preferred embodiment, the specific preparation process of the optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one is as follows:
(1) adding a mixture of 1: 6-8 parts of 2-hydroxy-5-bromoacetophenone (V) and sodium hydride, adding a solvent, reacting for 2-4 hours at the temperature of-2 ℃, adding a quenching agent after the reaction is finished, extracting, drying, evaporating the solvent, and performing column chromatography separation by using petroleum ether/ethyl acetate to obtain a first intermediate shown in a formula (VI);
(2) adding a second palladium catalyst, a second phosphine ligand, a second alkali reagent and a second solvent into the first intermediate, reacting for 10-14 hours under the conditions of carbon monoxide and 90-110 ℃, adding a quenching agent after the reaction is finished, extracting, drying, evaporating the solvent, and performing column chromatography separation by using petroleum ether/ethyl acetate to obtain a second intermediate shown in a formula (III);
(3) in a glove box, a reaction flask was charged with a mixture of 1: 1-3 of 1-benzopyran-4-one and diphenylphosphine oxide, adding a chiral bis-nitroxide ligand as a chiral ligand, adding scandium trifluoromethanesulfonate as Lewis acid, adding alkali, a solvent and 4-dimethylaminopyridine into the system, reacting for 40-50 hours at-5 ℃, and performing column chromatography separation after the reaction is finished to obtain a chiral target product (S) -2- (diphenylphosphinoyl) chromium-4-one as shown in a formula (I); the specific reaction process is as follows:
Figure BDA0002599141990000031
further, as a preferred embodiment, the first solvent in step (1) is ethyl formate, and the quenching agent is methanol.
Further, as a preferred embodiment, in the step (2), the second palladium ligand is palladium acetate, the second phosphine ligand is 1, 3-bis (diphenylphosphino) propane, the second base is N, N-diisopropylethylamine, the second solvent is dimethyl sulfoxide and methanol, and the quencher is water.
Further, as a preferred embodiment, in the step (3), the base is lithium carbonate, and the solvent is tetrahydrofuran.
Further, as a preferred embodiment, the addition amount of the chiral ligand in the step (3) is 6 mol%; the addition amount of the scandium trifluoromethanesulfonate was 5 mol%.
Further, in order to improve the purity of the product, the chiral target product is obtained by performing column chromatography separation on petroleum ether or ethyl acetate after the reaction in the step (3) is finished.
Has the advantages that: (1) the invention creatively researches the preparation method of optically pure (S) -2- (diphenylphosphinoyl) chromium-4-ketone, fills the vacancy of synthesizing the organic aryl phosphine compound in the Michael addition reaction in the metal catalysis asymmetry, effectively expands the synthesis method of the organic phosphine compound and improves the catalytic efficiency in the metal catalysis asymmetry; (2) in the invention, through the research on the conditions such as raw material characteristics, ligand structure, catalytic effect and the like, the addition catalyst and the metal are selected to match with the corresponding solvent in a targeted manner, so that the smooth proceeding of the reaction process is ensured, and the yield, the purity and the enantioselectivity of the product are improved.
Drawings
FIG. 1 is a drawing of the product of example 11H NMR spectrum;
FIG. 2 is a drawing of the product of example 113C NMR spectrum;
FIG. 3 is the product of example 21H NMR spectrum;
FIG. 4 is a graph of the product of example 213C NMR spectrum;
FIG. 5 is a photograph of the product of example 31H NMR spectrum;
FIG. 6 is a graph of the product of example 313C NMR spectrum;
FIG. 7 is a graph of the product of example 331A P NMR spectrum;
FIG. 8 is an HPLC chromatogram of the product of example 3.
Detailed Description
The technical solution of the present invention is described in detail below with reference to the accompanying drawings, but the scope of the present invention is not limited to the embodiments. The reaction drugs used in the examples are all conventionally commercially available.
Example 1: preparation of the first intermediate
Adding 645mg of 2-hydroxy-5-bromoacetophenone into a dry reaction bottle, adding 6ml of ethyl formate solution, cooling the reaction system to 0 ℃, and keeping the temperature for 5 minutes; adding 720mg of sodium hydride into the reaction system for four times in 2 hours, heating to room temperature, reacting for 30 minutes, quenching by 1.3ml of methanol, adding 12.5ml of concentrated hydrochloric acid, and stirring at room temperature for reacting overnight; after the reaction, 10ml of ethyl acetate was dissolved, washed with 10ml of water, 10ml of saturated sodium bicarbonate, 10ml of x 3 times of ethyl acetate, and the resulting organic phases were combined and dried, and the solvent was removed under reduced pressure to obtain a crude product. The crude product was purified by column chromatography eluting with n-hexane and ethyl acetate at a ratio of 10:1 to give 544mg of the first intermediate in 81% yield.
The structural characterization data for the product (VI) obtained in example 1 are as follows:
1H NMR(500MHz,CDCl3):δ7.85(d,J=6.1Hz,1H),7.82(dd,J=8.2,3.1Hz,1H),7.46(dd,J=9.2,4.2Hz,1H),7.38(ddd,J=9.2,7.6,3.1Hz,1H),6.32(d,J=6.0Hz,1H).
13C NMR(126MHz,CDCl3):δ176.76(d,J=2.3Hz),160.46,158.50,155.42,152.70(d,J=1.8Hz),126.00(d,J=7.3Hz),122.08,121.87,120.31(d,J=8.2Hz),112.20,110.72,110.53.
the successful synthesis of the first intermediate is proved by the nuclear magnetic resonance hydrogen spectrum and the carbon spectrum of the product.
HRMS:calculated for C9H5BrO2(M+H)+:223.9473,found:223.9473.
The second intermediate is successfully synthesized, and the yield and the purity are higher.
Example 2: preparation of the second intermediate
544mg of the first intermediate, 108mg of palladium acetate, 198mg of 1, 3-bis (diphenylphosphino) propane, 2.2ml of N, N-diisopropylethylamine were added to a dry two-necked reaction flask, followed by addition of 7.2ml of a dimethyl sulfoxide solution and 7.2ml of a methanol solution; replacing carbon monoxide gas for three times for the reaction system, and then heating the reaction system to 100 ℃ to react for 12 hours at the temperature; after the reaction, 20ml of water is added for quenching, 20ml of ethyl acetate with the power of 3 times is used for quenching, the obtained organic phases are combined and dried, and the solvent is removed under reduced pressure to obtain a crude product. The crude product was purified by column chromatography eluting with n-hexane and ethyl acetate at a ratio of 10:1 to give 413mg of the second intermediate in 85% yield.
The structural characterization data of the product (III) obtained in example 2 are as follows:
1H NMR(500MHz,CDCl3):δ8.84(d,J=2.1Hz,1H),8.28(dd,J=8.8,2.2Hz,1H),7.85(d,J=6.0Hz,1H),7.48(d,J=8.8Hz,1H),6.35(d,J=6.1Hz,1H),3.92(s,3H).
13C NMR(126MHz,CDCl3):δ176.81,165.57,158.82,155.35,134.29,128.22,124.43,118.59,113.38,52.36.
the successful synthesis of the second intermediate is proved by the nuclear magnetic resonance hydrogen spectrum and the carbon spectrum of the product.
HRMS:calculated for C11H8O4(M+H)+:204.0423,found:204.0423.
The second intermediate is successfully synthesized, and the yield and the purity are higher.
Example 3: optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one
In a glove box, adding 46mg of the second intermediate, 6.2mg of scandium trifluoromethanesulfonate, 9.3mg of chiral dinitrogen ligand, 3.1mg of 4-dimethylaminopyridine and 35mg of lithium carbonate into a dry reaction tube in sequence, adding 2.5ml of tetrahydrofuran solution, stirring vigorously at room temperature for 1 hour, cooling the reaction system to 0 ℃ after stirring, keeping the temperature for 5 minutes, quickly adding 50mg of diphenylphosphine oxide into the reaction system, and reacting for 48 hours at 0 ℃; after the reaction is finished, the solvent is removed under reduced pressure to obtain a crude product. The crude product was purified by column chromatography eluting with n-hexane and ethyl acetate in a ratio of 2:1 to give 55mg of optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one in 54% yield and 90% ee, the enantiomeric purity being determined by chiral HPLC analysis.
The structural characterization data of the product (I) obtained in example 1 are shown below:
1H NMR(500MHz,CDCl3):δ8.55(d,J=2.2Hz,1H),8.13(dd,J=8.8,2.2Hz,1H),7.99–7.85(m,4H),7.67–7.58(m,2H),7.59–7.50(m,4H),7.00(d,J=8.7Hz,1H),5.35(dt,J=13.7,3.4Hz,1H),3.90(s,3H),3.10–2.93(m,2H).
13C NMR(126MHz,CDCl3):δ188.74(d,J=13.0Hz),165.74,163.70(d,J=11.4Hz),136.87,132.93(t,J=3.5Hz),132.25(d,J=9.2Hz),131.48(d,J=9.3Hz),129.80,129.53,128.96(dd,J=23.7,12.1Hz),128.34,127.54,124.57,120.71,118.18,75.61(d,J=87.2Hz),52.29,35.85.
31P NMR(162MHz,CDCl3):δ26.73.
the successful synthesis of the optically pure (S) -2- (diphenylphosphine) chromium-4-one compound is proved by the nuclear magnetic resonance hydrogen spectrum, carbon spectrum and phosphine spectrum of the product.
The specific optical rotation of the compound of formula (I) [ alpha ]]D 25=-30°(c=0.10,MeOH).
HRMS:calculated for C23H19O3P(M+H)+:407.1043,found 407.1043.
HPLC:Daicel Chiralpak IA-3column,n-hexane/i-PrOH(80/20),1.0mL/min,254nm,15.548min(minor enantiomer),17.301min(major enantiomer).
The results prove that the optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone is successfully synthesized, the yield and the purity are high, and high enantioselectivity can be obtained.
As noted above, while the present invention has been shown and described with reference to certain preferred embodiments, it is not to be construed as limited thereto. Various changes in form and detail may be made therein without departing from the spirit and scope of the invention as defined by the appended claims.

Claims (8)

1. An optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one, characterized by the formula (I):
Figure FDA0002599141980000011
wherein: r is 6-F, 6-Cl, 6-Br, 6-OMe, 6-CO2Me、6-NO25-Me, 6-Me, 7-Me or 8-Me;
ar is C6H5-、2-Me-C6H4-、3-Me-C6H4-、4-Me-C6H4-、4-F-C6H4-or 2-naphthyl-.
2. A process for the preparation of optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one according to claim 1, characterized in that: carrying out Michael addition reaction on 1-benzopyran-4-one and diphenylphosphine oxide under the catalytic action of a composite catalyst to obtain optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one; the composite catalyst is a mixture of a chiral dinitrogen ligand and scandium trifluoromethanesulfonate, wherein the structural formula of the chiral dinitrogen ligand is shown as the formula (II):
Figure FDA0002599141980000012
3. the process for preparing optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one according to claim 2, comprising the steps of:
(1) adding a mixture of 1: 6-8 parts of 2-hydroxy-5-bromoacetophenone (V) and sodium hydride, adding a first solvent, reacting for 2-4 hours at the temperature of-2 ℃, adding a quenching agent after the reaction is finished, extracting, drying, evaporating the solvent, and performing column chromatography separation by using petroleum ether/ethyl acetate to obtain a first intermediate shown in a formula (VI);
(2) adding a second palladium catalyst, a second phosphine ligand, a second alkali reagent and a second solvent into the first intermediate, reacting for 10-14 hours under the conditions of carbon monoxide and 90-110 ℃, adding a quenching agent after the reaction is finished, extracting, drying, evaporating the solvent, and performing column chromatography separation by using petroleum ether/ethyl acetate to obtain a second intermediate shown in a formula (III);
(3) in a glove box, a reaction flask was charged with a mixture of 1: 1-3 of a second intermediate and a diphenylphosphine oxide, adding a chiral bis-nitroxide ligand as a chiral ligand, adding scandium trifluoromethanesulfonate as a Lewis acid, adding an alkali, a solvent and 4-dimethylaminopyridine into the system, reacting for 40-50 hours at-5 ℃, and performing column chromatography separation after the reaction is finished to obtain a chiral target product 2- (diphenylphosphine acyl) chromium-4-ketone, wherein the formula is shown in the formula (I);
the specific reaction process is as follows:
Figure FDA0002599141980000021
4. the method for preparing an optical chromone derivative according to claim 3, wherein: in the step (1), the first solvent is ethyl formate, and the quenching agent is methanol.
5. The method for preparing an optical chromone derivative according to claim 3, wherein: in the step (2), the second palladium ligand is palladium acetate, the second phosphine ligand is 1, 3-bis (diphenylphosphino) propane, the second base is N, N-diisopropylethylamine, the second solvent is dimethyl sulfoxide and methanol, and the quenching agent is water.
6. The process for preparing optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one according to claim 3, wherein: the alkali is lithium carbonate, and the solvent is tetrahydrofuran.
7. The process for preparing optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one according to claim 3, wherein: the addition amount of the chiral ligand is 6 mol%; the addition amount of the scandium trifluoromethanesulfonate was 5 mol%.
8. The process for preparing optically pure (S) -2- (diphenylphosphinoyl) chromium-4-one according to claim 3, wherein: after the reaction is finished, performing column chromatography separation by using petroleum ether or ethyl acetate to obtain a chiral target product.
CN202010718634.6A 2020-07-23 2020-07-23 Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof Pending CN113968882A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202010718634.6A CN113968882A (en) 2020-07-23 2020-07-23 Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202010718634.6A CN113968882A (en) 2020-07-23 2020-07-23 Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof

Publications (1)

Publication Number Publication Date
CN113968882A true CN113968882A (en) 2022-01-25

Family

ID=79585364

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202010718634.6A Pending CN113968882A (en) 2020-07-23 2020-07-23 Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof

Country Status (1)

Country Link
CN (1) CN113968882A (en)

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
RYOTA ISSHIKI ET AL: "Decarbonylative C-P Bond Formation Using Aromatic Esters and Organophosphorus Compounds", 《ORG. LETT.》 *
张欣: "新型手性双氮氧铟络合物催化酮的不对称烯丙基化反应研究", 《四川大学博士学位论文》 *

Similar Documents

Publication Publication Date Title
Zheng et al. Biomimetic catalytic enantioselective decarboxylative aldol reaction of β-ketoacids with trifluoromethyl ketones
CN107698590A (en) A kind of method of asymmetry [3+2] cyclization five yuan of carbocyclic purine nucleosides of synthesis of chiral
CN105728046A (en) Ruthenium metallic olefin metathesis catalyst and preparation and application methods thereof
EP1386901B1 (en) Method for producing an optically active beta-amino acid
JP5271503B2 (en) Method for producing organoboron compound
JP7464234B2 (en) Method for producing highly optically active allene carboxylic acid compounds having axial asymmetry
CN113968882A (en) Optically pure (S) -2- (diphenylphosphine acyl) chromium-4-ketone and preparation method thereof
CN111468183A (en) Polyfluoro triaryl chiral spiro phosphoric acid catalyst, and preparation method and application thereof
CN115108937B (en) Synthesis method of alpha-azido ketone containing three-level stereo center
CN113979983B (en) Asymmetric synthesis method of fidarestat key intermediate
EP1661903B1 (en) Novel transition metal complex and process for producing optically active alcohol with the complex
CN114315917B (en) Chiral ferrocene PNNO tetradentate ligand and application thereof in asymmetric hydrogenation reaction
CN111732542B (en) Optically pure binaphthyl NN-dioxide ligand and preparation method thereof
US7649117B2 (en) Process of preparing optically active β-hydroxycarboxylic acid derivative
CN112209850B (en) Method for preparing (S) -3-amino-2-benzyl methyl propionate
JP4368632B2 (en) Process for producing optically active β-amino acids
CN109503660B (en) Chiral monophosphine catalyst Le-Phos with cyclic phosphine skeleton and preparation method and application of full configuration thereof
CN109336845B (en) Optically active cyclopentane-3-imine and its derivative and preparation method
EP2098501B1 (en) Method for producing optically active fluorine-containing carbonyl-ene product
Kim et al. Concise catalytic asymmetric total syntheses of ancistrocladinium A and its atropdiastereomer
CN100497335C (en) Optical resolution method substituting oxyphosphonate acetate
CN100488969C (en) Optically active substituted oxyphosphonate salt acetate and its use
JP4004547B2 (en) Method for producing optically active amine
CN111635432A (en) Trost ligand with axial chiral binaphthyl skeleton and preparation method thereof
JP2005518339A (en) Process for producing enantiomerically rich N-acyl-β-amino acid derivatives by enantioselective hydrogenation of the corresponding (Z) enamide

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination